Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 3 art units • 3 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Morehouse School of Medicine maintains a portfolio in the Biotechnology & Pharmaceuticals technology area with 6 pending office actions. These actions are distributed among 2 distinct examiners and 2 distinct art units. This distribution shows a high concentration of work per examiner compared to portfolios with more diverse staffing.
SITTON, JEHANNE SOUAYA serves as the busiest examiner for the institution, managing 4 pending office actions. This represents a significant portion of the total 6 pending office actions. The remaining actions are handled by the other distinct examiner.
The use of only 2 distinct art units suggests that the pending applications share closely related technical subject matter. Practitioners should monitor the actions under SITTON, JEHANNE SOUAYA for potential examiner-specific trends or recurring rejections. The high volume of 4 pending office actions with a single examiner creates a focal point for the school's prosecution strategy across the 2 distinct art units. This concentration allows for a highly specialized approach to the current workload.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 1 (17%) |
| §112 only | 1 (17%) |
| Double-patenting + other | 2 (33%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SITTON, JEHANNE SOUAYA | 3 | 53.2% | +47.5% |
| AUDET, MAURY A | 2 | 50.1% | +23.9% |
| STONE, RACHAEL SOJIN | 1 | 55.2% | +21.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19347102 | SYSTEM FOR REDUCING MATERNAL MORTALITY AND METHOD OF USE THEREOF | STONE, RACHAEL SOJIN | — |
| 17305480 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | SITTON, JEHANNE SOUAYA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18160366 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | SITTON, JEHANNE SOUAYA | 14d |
| 19347102 | SYSTEM FOR REDUCING MATERNAL MORTALITY AND METHOD OF USE THEREOF | STONE, RACHAEL SOJIN | — |
| 18536722 | METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES | AUDET, MAURY A | — |
| 18160373 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | SITTON, JEHANNE SOUAYA | — |
| 17662783 | METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES | AUDET, MAURY A | — |
| 17305480 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | SITTON, JEHANNE SOUAYA | — |
| Art Unit | Apps |
|---|---|
| 1682 | 3 |
| 1654 | 2 |
| 3681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19347102 | SYSTEM FOR REDUCING MATERNAL MORTALITY AND METHOD OF USE THEREOF | STONE, RACHAEL SOJIN | 3681 | §101§103Other | Non-Final OA | — | Pending | Oct 01, 2025 |
| 18536722 | METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES | AUDET, MAURY A | 1654 | §103DP | Final Rejection | — | Pending | Dec 12, 2023 |
| 18160373 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | SITTON, JEHANNE SOUAYA | 1682 | §103 | Non-Final OA | — | Pending | Jan 27, 2023 |
| 18160366 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | SITTON, JEHANNE SOUAYA | 1682 | §103DP | Final Rejection | 14d | Pending | Jan 27, 2023 |
| 17662783 | METHOD AND COMPOSITIONS FOR THE TREATMENT AND DETECTION OF ENDOTHELIN-1 RELATED KIDNEY DISEASES | AUDET, MAURY A | 1654 | §112 | Non-Final OA | — | Pending | May 10, 2022 |
| 17305480 | METHOD AND SYSTEM OF DIAGNOSING AND TREATING NEURODEGENERATIVE DISEASE AND SEIZURES | SITTON, JEHANNE SOUAYA | 1682 | §103§112 | Final Rejection | — | Pending | Jul 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMorehouse School of Medicine has 6 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Jehanne Souaya Sitton has the most, with 3 of Morehouse School of Medicine's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
